BMJ  2005;330:400 (19 February), doi:10.1136/bmj.38366.562685.8F (published 10 February 2005)

Learning in practice

Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme

V Jenkins, senior research fellow in psycho-oncology1, L Fallowfield, professor in psycho-oncology1, I Solis-Trapala, statistical researcher2, C Langridge, data manager1, V Farewell, senior scientist3

1 Sussex Psychosocial Oncology Group, Brighton & Sussex Medical School, University of Sussex, Brighton BN1 9QG, 2 Centro de Investigacion en Matematicas, Guanajuato, Mexico, 3 MRC Biostatistics Unit, Institute of Public Health, Cambridge

Correspondence to: V Jenkins val{at}sussex.ac.uk

Abstract

Objective To evaluate a training intervention aimed at improving healthcare professionals' communication with cancer patients about randomised clinical trials.

Design Before and after evaluation of training programme.

Setting Members of the National Cancer Research Network, Scottish Trials Network, and the Welsh Cancer Trials Network

Participants 101 healthcare professionals (33 clinicians and 68 research nurses).

Intervention Four modules delivered by a trained facilitator using videotapes and interactive exercises to cover general issues about discussing randomised clinical trials with patients, problems specific to adjuvant trials, trials with palliation as the goal, and trials where patients had a strong preference for one treatment arm.

Main outcome measures Before and after the intervention, participants were videotaped discussing a trial with an actor portraying a patient. These consultations were assessed for presence of information required by good clinical practice guidelines. The actor patients gave an assessment after each interview. Participants reported their self confidence about key aspects of trial discussion.

Results Analysis of the videotaped consultations showed that, after intervention, significantly more participants displayed key communication behaviours such as explaining randomisation (69 v 81, odds ratio 2.33, P = 0.033), checking patients' understanding (11 v 31, odds ratio 3.22, P = 0.002), and discussing standard treatment (73 v 88, odds ratio 4.75, P = 0.005) and side effects (69 v 85, odds ratio 3.29, P = 0.006). Participants' self confidence increased significantly (P < 0.001) across all areas. Actor patients' ratings of participants' communication showed significant improvements for 12/15 key items.

Conclusion This intensive 8 hour intervention significantly improved participants' confidence and competence when communicating about randomised clinical trials.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Rasco, D. W., Xie, Y., Yan, J., Sayne, J. R., Skinner, C. S., Dowell, J. E., Gerber, D. E. (2009). The Impact of Consenter Characteristics and Experience on Patient Interest in Clinical Research. The Oncologist 14: 468-475 [Abstract] [Full text]  
  • Donnelly, P, Hiller, L, Bathers, S, Bowden, S, Coleman, R (2007). Questioning specialists' attitudes to breast cancer follow-up in primary care. Ann Oncol 18: 1467-1476 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

RCTs gold or copper?!
Dr Payam Fazel MD
bmj.com, 4 Sep 2007 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ